<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03572426</url>
  </required_header>
  <id_info>
    <org_study_id>17-1578</org_study_id>
    <nct_id>NCT03572426</nct_id>
  </id_info>
  <brief_title>Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder</brief_title>
  <official_title>Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sigma Theta Tau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Genotype 164 adults to evaluate six selected single nucleotide polymorphisms (SNPs)
      (rs1006737, rs10994336, rs10994133, rs2238071, rs1051375, rs1024582) for use as a genetic
      biomarker to differentiate between bipolar depression and unipolar depression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adults ages 18-80 will be recruited if they are diagnosed with bipolar disorder, major
      depression, or have no mood symptoms. The adults will undergo a diagnostic interview, the
      Mini International Neuropsychiatric Interview (MINI) for the diagnosis. The subjects will
      also complete the Adverse Childhood Events Scale to evaluate for a genetic x environmental
      interaction in detecting bipolar disorder at initial assessment. Genotyping will be done by
      SNaPshot genotyping method and genetic sample will be collected via buccal swab.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 13, 2018</start_date>
  <completion_date type="Actual">April 4, 2019</completion_date>
  <primary_completion_date type="Actual">April 4, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Logistic Regression</measure>
    <time_frame>1 year</time_frame>
    <description>Logistic regression will be used to examine a genetic risk score using a risk allele count as the independent variable, with a diagnosis of BD versus MDD versus those with no mood diagnosis as the dependent variable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Genetic Risk Score</measure>
    <time_frame>1 year</time_frame>
    <description>Genetic risk score of selected SNPsrs1006737, rs10994336, rs10994133, rs2238071, rs1051375, rs1024582</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Family History</measure>
    <time_frame>1 year</time_frame>
    <description>Positive family history of bipolar disorder in a first degree relative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Childhood Experiences Scale</measure>
    <time_frame>1 year</time_frame>
    <description>0-10 item scale assessing for adversity experienced during childhood</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">164</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>Bipolar</arm_group_label>
    <description>Diagnosed as having at least 1 lifetime manic episode by the MINI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Depression</arm_group_label>
    <description>Diagnosed as having at least 1 Major Depressive Episode by the MINI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Does not meet Criteria for any mood disorder diagnosis (MDD, BD, dysthymia)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>genotyping all subjects</intervention_name>
    <description>genotyping using SNaPshot genotyping method.</description>
    <arm_group_label>Bipolar</arm_group_label>
    <arm_group_label>Depression</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Buccal Swab collect with genotyping done by SNaPshot.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Caucasian and Latino
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presenting to one of 4 Denver Metro Area clinics

          -  Subjects must fall into one of 3 diagnostic categories, bipolar, MDD, or no mood
             symptoms.

        Exclusion Criteria:

          -  Inability to provide informed consent

          -  history of TBI

          -  history of untreated seizure disorder

          -  substance abuse in the last 8 hours

          -  moderate-severe substance abuse disorder diagnosed in the last 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Kristiana Avery, PhD-c</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helen and Arthur E Johnson Depression Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 13, 2018</study_first_submitted>
  <study_first_submitted_qc>June 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2018</study_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

